Bayesian Methods for Predicting Interacting Protein Pairs Using Domain Information
From MaRDI portal
Recommendations
Cites work
Cited in
(47)- Estimating the prevalence of multiple diseases from two-stage hierarchical pooling
- Informative Dorfman screening
- Optimal Group Testing: Structural Properties and Robust Solutions, with Application to Public Health Screening
- Three-Dimensional Array-Based Group Testing Algorithms
- Estimating the prevalence of two or more diseases using outcomes from multiplex group testing
- Discussion on: ``Is group testing ready for prime-time in disease identification?
- Group testing regression models with dilution submodels
- Screening multi‐dimensional heterogeneous populations for infectious diseases under scarce testing resources, with application to <scp>COVID</scp>‐19
- Static Risk-Based Group Testing Schemes Under Imperfectly Observable Risk
- Revisiting Nested Group Testing Procedures: New Results, Comparisons, and Robustness
- Capturing the dilution effect of risk-based grouping with application to COVID-19 screening
- Optimal Screening of Populations with Heterogeneous Risk Profiles Under the Availability of Multiple Tests
- Known mean, unknown maxima? Testing the maximum knowing only the mean
- Group Testing Regression Analysis with Missing Data and Imperfect Tests
- Optimal Dorfman group testing for symmetric distributions
- Is group testing ready for prime-time in disease identification?
- The objective function controversy for group testing: much ado about nothing?
- Group testing case identification with biomarker information
- Estimation of odds ratio from group testing data with misclassified exposure
- Incorporating retesting outcomes for estimation of disease prevalence
- Incorporating the dilution effect in group testing regression
- Informative array testing with multiplex assays
- Array-based schemes for group screening with test errors which incorporate a concentration effect
- Two-dimensional informative array testing
- Two-stage hierarchical group testing for multiple infections with application to the infertility prevention project
- Group testing regression model estimation when case identification is a goal
- Prediction-driven pooled testing methods: application to HIV treatment monitoring in Rakai, Uganda
- Regression analysis and variable selection for two-stage multiple-infection group testing data
- Capturing the pool dilution effect in group testing regression: a Bayesian approach
- Structure-aware combinatorial group testing: a new method for pandemic screening
- Robust group testing for multiple traits with misclassification
- Hierarchical group testing for multiple infections
- Group testing regression models with fixed and random effects
- Optimizing pooled testing for estimating the prevalence of multiple diseases
- Optimal configuration of a square array group testing algorithm
- Statistical modeling for practical pooled testing during the COVID-19 pandemic
- Extensions of Dorfman's theory
- Optimizing disease surveillance through pooled testing with application to infectious diseases
- A general regression framework for group testing data, which incorporates pool dilution effects
- Nested group testing procedure
- Group testing for case identification with correlated responses
- Bayesian additive regression trees for group testing data
- Residual risk and waste in donated blood with pooled nucleic acid testing
- Estimating proportions by group retesting with unequal group sizes at each stage
- groupTesting: an R package for group testing estimation
- Regression models for group testing: identifiability and asymptotics
- Optimal allocation of gold standard testing under constrained availability: application to assessment of HIV treatment failure
This page was built for publication: Bayesian Methods for Predicting Interacting Protein Pairs Using Domain Information
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q5449916)
